McKinsey's $78M Opioid Deal With Health Plans Hits Snag

By Gina Kim · February 2, 2024, 10:37 PM EST

A California federal judge considering a $78 million deal between third-party payors and McKinsey & Co. in multidistrict litigation over the consulting firm's marketing advice to opioid makers held off on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

In re: McKinsey & Co., Inc. National Prescription Opiate Consultant Litigation

Case Number

3:21-md-02996

Court

California Northern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

June 08, 2021